ADMA vs TRV · P/E 22, rev $238.9M vs P/E 14, rev $12.15B
ADMA Biologics Inc (ADMA) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported TRV revenue for 2026-06-30 was $12.15B. Net income was $2.21B. Revenue was up 1.9% from 2026-03-31 to 2026-06-30. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the ADMA and TRV stock pages for the full models.
Not investment advice.